 | • レポートコード：GIR-107A11898 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、皮膚がんのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。皮膚がんの種類別市場規模（細胞がん、扁平上皮がん、黒色腫、その他）、用途別市場規模（病院・クリニック、診断センター、がん研究所）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・皮膚がんの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Roche、Novartis、Sun Pharma、Elekta、Varian Medical Systems、Cannabis Science、Cellceutix、LEO Pharma、Moberg Pharma、Mylan、Eli Lilly、Bristol Myers Squibb、Boehringer Ingelheim、Aqua Pharmaceuticals、Bausch Health、Merck ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：細胞がん、扁平上皮がん、黒色腫、その他 ・用途別分析2016年-2026年：病院・クリニック、診断センター、がん研究所 ・皮膚がんの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・皮膚がんのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・皮膚がんのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・皮膚がんの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・皮膚がんの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Skin Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Skin Cancer size is estimated to be USD 623.2 million in 2026 from USD 516.9 million in 2020, with a change XX% between 2020 and 2021. The global Skin Cancer market size is expected to grow at a CAGR of 4.8% for the next five years.
Market segmentation
Skin Cancer market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Cell carcinoma
Squamous-cell Carcinoma
Melanoma
Others
Market segment by Application, can be divided into
Hospital and Clinics
Diagnostic Centers
Cancer Research Institute
Market segment by players, this report covers
Roche
Novartis
Sun Pharma
Elekta
Varian Medical Systems
Cannabis Science
Cellceutix
LEO Pharma
Moberg Pharma
Mylan
Eli Lilly
Bristol Myers Squibb
Boehringer Ingelheim
Aqua Pharmaceuticals
Bausch Health
Merck
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Skin Cancer product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Skin Cancer, with revenue, gross margin and global market share of Skin Cancer from 2019 to 2021.
Chapter 3, the Skin Cancer competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Skin Cancer market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Skin Cancer research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Skin Cancer
1.2 Classification of Skin Cancer by Type
1.2.1 Overview: Global Skin Cancer Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Skin Cancer Revenue Market Share by Type in 2020
1.2.3 Cell carcinoma
1.2.4 Squamous-cell Carcinoma
1.2.5 Melanoma
1.2.6 Others
1.3 Global Skin Cancer Market by Application
1.3.1 Overview: Global Skin Cancer Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital and Clinics
1.3.3 Diagnostic Centers
1.3.4 Cancer Research Institute
1.4 Global Skin Cancer Market Size & Forecast
1.5 Global Skin Cancer Market Size and Forecast by Region
1.5.1 Global Skin Cancer Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Skin Cancer Market Size by Region, (2016-2021)
1.5.3 North America Skin Cancer Market Size and Prospect (2016-2026)
1.5.4 Europe Skin Cancer Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Skin Cancer Market Size and Prospect (2016-2026)
1.5.6 South America Skin Cancer Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Skin Cancer Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Skin Cancer Market Drivers
1.6.2 Skin Cancer Market Restraints
1.6.3 Skin Cancer Trends Analysis
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Skin Cancer Product and Solutions
2.1.4 Roche Skin Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Roche Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Skin Cancer Product and Solutions
2.2.4 Novartis Skin Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Sun Pharma
2.3.1 Sun Pharma Details
2.3.2 Sun Pharma Major Business
2.3.3 Sun Pharma Skin Cancer Product and Solutions
2.3.4 Sun Pharma Skin Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Sun Pharma Recent Developments and Future Plans
2.4 Elekta
2.4.1 Elekta Details
2.4.2 Elekta Major Business
2.4.3 Elekta Skin Cancer Product and Solutions
2.4.4 Elekta Skin Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Elekta Recent Developments and Future Plans
2.5 Varian Medical Systems
2.5.1 Varian Medical Systems Details
2.5.2 Varian Medical Systems Major Business
2.5.3 Varian Medical Systems Skin Cancer Product and Solutions
2.5.4 Varian Medical Systems Skin Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Varian Medical Systems Recent Developments and Future Plans
2.6 Cannabis Science
2.6.1 Cannabis Science Details
2.6.2 Cannabis Science Major Business
2.6.3 Cannabis Science Skin Cancer Product and Solutions
2.6.4 Cannabis Science Skin Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Cannabis Science Recent Developments and Future Plans
2.7 Cellceutix
2.7.1 Cellceutix Details
2.7.2 Cellceutix Major Business
2.7.3 Cellceutix Skin Cancer Product and Solutions
2.7.4 Cellceutix Skin Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Cellceutix Recent Developments and Future Plans
2.8 LEO Pharma
2.8.1 LEO Pharma Details
2.8.2 LEO Pharma Major Business
2.8.3 LEO Pharma Skin Cancer Product and Solutions
2.8.4 LEO Pharma Skin Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 LEO Pharma Recent Developments and Future Plans
2.9 Moberg Pharma
2.9.1 Moberg Pharma Details
2.9.2 Moberg Pharma Major Business
2.9.3 Moberg Pharma Skin Cancer Product and Solutions
2.9.4 Moberg Pharma Skin Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Moberg Pharma Recent Developments and Future Plans
2.10 Mylan
2.10.1 Mylan Details
2.10.2 Mylan Major Business
2.10.3 Mylan Skin Cancer Product and Solutions
2.10.4 Mylan Skin Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Mylan Recent Developments and Future Plans
2.11 Eli Lilly
2.11.1 Eli Lilly Details
2.11.2 Eli Lilly Major Business
2.11.3 Eli Lilly Skin Cancer Product and Solutions
2.11.4 Eli Lilly Skin Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Eli Lilly Recent Developments and Future Plans
2.12 Bristol Myers Squibb
2.12.1 Bristol Myers Squibb Details
2.12.2 Bristol Myers Squibb Major Business
2.12.3 Bristol Myers Squibb Skin Cancer Product and Solutions
2.12.4 Bristol Myers Squibb Skin Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Bristol Myers Squibb Recent Developments and Future Plans
2.13 Boehringer Ingelheim
2.13.1 Boehringer Ingelheim Details
2.13.2 Boehringer Ingelheim Major Business
2.13.3 Boehringer Ingelheim Skin Cancer Product and Solutions
2.13.4 Boehringer Ingelheim Skin Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Boehringer Ingelheim Recent Developments and Future Plans
2.14 Aqua Pharmaceuticals
2.14.1 Aqua Pharmaceuticals Details
2.14.2 Aqua Pharmaceuticals Major Business
2.14.3 Aqua Pharmaceuticals Skin Cancer Product and Solutions
2.14.4 Aqua Pharmaceuticals Skin Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Aqua Pharmaceuticals Recent Developments and Future Plans
2.15 Bausch Health
2.15.1 Bausch Health Details
2.15.2 Bausch Health Major Business
2.15.3 Bausch Health Skin Cancer Product and Solutions
2.15.4 Bausch Health Skin Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Bausch Health Recent Developments and Future Plans
2.16 Merck
2.16.1 Merck Details
2.16.2 Merck Major Business
2.16.3 Merck Skin Cancer Product and Solutions
2.16.4 Merck Skin Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Merck Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Skin Cancer Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Skin Cancer Players Market Share
3.2.2 Top 10 Skin Cancer Players Market Share
3.2.3 Market Competition Trend
3.3 Skin Cancer Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Skin Cancer Revenue and Market Share by Type (2016-2021)
4.2 Global Skin Cancer Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Skin Cancer Revenue Market Share by Application (2016-2021)
5.2 Skin Cancer Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Skin Cancer Revenue by Type (2016-2026)
6.2 North America Skin Cancer Revenue by Application (2016-2026)
6.3 North America Skin Cancer Market Size by Country
6.3.1 North America Skin Cancer Revenue by Country (2016-2026)
6.3.2 United States Skin Cancer Market Size and Forecast (2016-2026)
6.3.3 Canada Skin Cancer Market Size and Forecast (2016-2026)
6.3.4 Mexico Skin Cancer Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Skin Cancer Revenue by Type (2016-2026)
7.2 Europe Skin Cancer Revenue by Application (2016-2026)
7.3 Europe Skin Cancer Market Size by Country
7.3.1 Europe Skin Cancer Revenue by Country (2016-2026)
7.3.2 Germany Skin Cancer Market Size and Forecast (2016-2026)
7.3.3 France Skin Cancer Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Skin Cancer Market Size and Forecast (2016-2026)
7.3.5 Russia Skin Cancer Market Size and Forecast (2016-2026)
7.3.6 Italy Skin Cancer Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Skin Cancer Revenue by Type (2016-2026)
8.2 Asia-Pacific Skin Cancer Revenue by Application (2016-2026)
8.3 Asia-Pacific Skin Cancer Market Size by Region
8.3.1 Asia-Pacific Skin Cancer Revenue by Region (2016-2026)
8.3.2 China Skin Cancer Market Size and Forecast (2016-2026)
8.3.3 Japan Skin Cancer Market Size and Forecast (2016-2026)
8.3.4 South Korea Skin Cancer Market Size and Forecast (2016-2026)
8.3.5 India Skin Cancer Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Skin Cancer Market Size and Forecast (2016-2026)
8.3.7 Australia Skin Cancer Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Skin Cancer Revenue by Type (2016-2026)
9.2 South America Skin Cancer Revenue by Application (2016-2026)
9.3 South America Skin Cancer Market Size by Country
9.3.1 South America Skin Cancer Revenue by Country (2016-2026)
9.3.2 Brazil Skin Cancer Market Size and Forecast (2016-2026)
9.3.3 Argentina Skin Cancer Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Skin Cancer Revenue by Type (2016-2026)
10.2 Middle East & Africa Skin Cancer Revenue by Application (2016-2026)
10.3 Middle East & Africa Skin Cancer Market Size by Country
10.3.1 Middle East & Africa Skin Cancer Revenue by Country (2016-2026)
10.3.2 Turkey Skin Cancer Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Skin Cancer Market Size and Forecast (2016-2026)
10.3.4 UAE Skin Cancer Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Skin Cancer Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Skin Cancer Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Skin Cancer Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Skin Cancer Revenue (USD Million) by Region (2016-2021)
Table 5. Global Skin Cancer Revenue Market Share by Region (2021-2026)
Table 6. Roche Corporate Information, Head Office, and Major Competitors
Table 7. Roche Major Business
Table 8. Roche Skin Cancer Product and Solutions
Table 9. Roche Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Novartis Corporate Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Skin Cancer Product and Solutions
Table 13. Novartis Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Sun Pharma Corporate Information, Head Office, and Major Competitors
Table 15. Sun Pharma Major Business
Table 16. Sun Pharma Skin Cancer Product and Solutions
Table 17. Sun Pharma Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Elekta Corporate Information, Head Office, and Major Competitors
Table 19. Elekta Major Business
Table 20. Elekta Skin Cancer Product and Solutions
Table 21. Elekta Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Varian Medical Systems Corporate Information, Head Office, and Major Competitors
Table 23. Varian Medical Systems Major Business
Table 24. Varian Medical Systems Skin Cancer Product and Solutions
Table 25. Varian Medical Systems Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Cannabis Science Corporate Information, Head Office, and Major Competitors
Table 27. Cannabis Science Major Business
Table 28. Cannabis Science Skin Cancer Product and Solutions
Table 29. Cannabis Science Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Cellceutix Corporate Information, Head Office, and Major Competitors
Table 31. Cellceutix Major Business
Table 32. Cellceutix Skin Cancer Product and Solutions
Table 33. Cellceutix Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. LEO Pharma Corporate Information, Head Office, and Major Competitors
Table 35. LEO Pharma Major Business
Table 36. LEO Pharma Skin Cancer Product and Solutions
Table 37. LEO Pharma Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Moberg Pharma Corporate Information, Head Office, and Major Competitors
Table 39. Moberg Pharma Major Business
Table 40. Moberg Pharma Skin Cancer Product and Solutions
Table 41. Moberg Pharma Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Mylan Corporate Information, Head Office, and Major Competitors
Table 43. Mylan Major Business
Table 44. Mylan Skin Cancer Product and Solutions
Table 45. Mylan Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 47. Eli Lilly Major Business
Table 48. Eli Lilly Skin Cancer Product and Solutions
Table 49. Eli Lilly Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Bristol Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 51. Bristol Myers Squibb Major Business
Table 52. Bristol Myers Squibb Skin Cancer Product and Solutions
Table 53. Bristol Myers Squibb Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
Table 55. Boehringer Ingelheim Major Business
Table 56. Boehringer Ingelheim Skin Cancer Product and Solutions
Table 57. Boehringer Ingelheim Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Aqua Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 59. Aqua Pharmaceuticals Major Business
Table 60. Aqua Pharmaceuticals Skin Cancer Product and Solutions
Table 61. Aqua Pharmaceuticals Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Bausch Health Corporate Information, Head Office, and Major Competitors
Table 63. Bausch Health Major Business
Table 64. Bausch Health Skin Cancer Product and Solutions
Table 65. Bausch Health Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Merck Corporate Information, Head Office, and Major Competitors
Table 67. Merck Major Business
Table 68. Merck Skin Cancer Product and Solutions
Table 69. Merck Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Global Skin Cancer Revenue (USD Million) by Players (2019-2021)
Table 71. Global Skin Cancer Revenue Share by Players (2019-2021)
Table 72. Breakdown of Skin Cancer by Company Type (Tier 1, Tier 2 and Tier 3)
Table 73. Skin Cancer Players Head Office, Products and Services Provided
Table 74. Skin Cancer Mergers & Acquisitions in the Past Five Years
Table 75. Skin Cancer New Entrants and Expansion Plans
Table 76. Global Skin Cancer Revenue (USD Million) by Type (2016-2021)
Table 77. Global Skin Cancer Revenue Share by Type (2016-2021)
Table 78. Global Skin Cancer Revenue Forecast by Type (2021-2026)
Table 79. Global Skin Cancer Revenue by Application (2016-2021)
Table 80. Global Skin Cancer Revenue Forecast by Application (2021-2026)
Table 81. North America Skin Cancer Revenue by Type (2016-2021) & (USD Million)
Table 82. North America Skin Cancer Revenue by Type (2021-2026) & (USD Million)
Table 83. North America Skin Cancer Revenue by Application (2016-2021) & (USD Million)
Table 84. North America Skin Cancer Revenue by Application (2021-2026) & (USD Million)
Table 85. North America Skin Cancer Revenue by Country (2016-2021) & (USD Million)
Table 86. North America Skin Cancer Revenue by Country (2021-2026) & (USD Million)
Table 87. Europe Skin Cancer Revenue by Type (2016-2021) & (USD Million)
Table 88. Europe Skin Cancer Revenue by Type (2021-2026) & (USD Million)
Table 89. Europe Skin Cancer Revenue by Application (2016-2021) & (USD Million)
Table 90. Europe Skin Cancer Revenue by Application (2021-2026) & (USD Million)
Table 91. Europe Skin Cancer Revenue by Country (2016-2021) & (USD Million)
Table 92. Europe Skin Cancer Revenue by Country (2021-2026) & (USD Million)
Table 93. Asia-Pacific Skin Cancer Revenue by Type (2016-2021) & (USD Million)
Table 94. Asia-Pacific Skin Cancer Revenue by Type (2021-2026) & (USD Million)
Table 95. Asia-Pacific Skin Cancer Revenue by Application (2016-2021) & (USD Million)
Table 96. Asia-Pacific Skin Cancer Revenue by Application (2021-2026) & (USD Million)
Table 97. Asia-Pacific Skin Cancer Revenue by Region (2016-2021) & (USD Million)
Table 98. Asia-Pacific Skin Cancer Revenue by Region (2021-2026) & (USD Million)
Table 99. South America Skin Cancer Revenue by Type (2016-2021) & (USD Million)
Table 100. South America Skin Cancer Revenue by Type (2021-2026) & (USD Million)
Table 101. South America Skin Cancer Revenue by Application (2016-2021) & (USD Million)
Table 102. South America Skin Cancer Revenue by Application (2021-2026) & (USD Million)
Table 103. South America Skin Cancer Revenue by Country (2016-2021) & (USD Million)
Table 104. South America Skin Cancer Revenue by Country (2021-2026) & (USD Million)
Table 105. Middle East & Africa Skin Cancer Revenue by Type (2016-2021) & (USD Million)
Table 106. Middle East & Africa Skin Cancer Revenue by Type (2021-2026) & (USD Million)
Table 107. Middle East & Africa Skin Cancer Revenue by Application (2016-2021) & (USD Million)
Table 108. Middle East & Africa Skin Cancer Revenue by Application (2021-2026) & (USD Million)
Table 109. Middle East & Africa Skin Cancer Revenue by Country (2016-2021) & (USD Million)
Table 110. Middle East & Africa Skin Cancer Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Skin Cancer Picture
Figure 2. Global Skin Cancer Revenue Market Share by Type in 2020
Figure 3. Cell carcinoma
Figure 4. Squamous-cell Carcinoma
Figure 5. Melanoma
Figure 6. Others
Figure 7. Skin Cancer Revenue Market Share by Application in 2020
Figure 8. Hospital and Clinics Picture
Figure 9. Diagnostic Centers Picture
Figure 10. Cancer Research Institute Picture
Figure 11. Global Skin Cancer Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Skin Cancer Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Skin Cancer Revenue Market Share by Region (2016-2026)
Figure 14. Global Skin Cancer Revenue Market Share by Region in 2020
Figure 15. North America Skin Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Skin Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Skin Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Skin Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Skin Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Skin Cancer Market Drivers
Figure 21. Skin Cancer Market Restraints
Figure 22. Skin Cancer Market Trends
Figure 23. Roche Recent Developments and Future Plans
Figure 24. Novartis Recent Developments and Future Plans
Figure 25. Sun Pharma Recent Developments and Future Plans
Figure 26. Elekta Recent Developments and Future Plans
Figure 27. Varian Medical Systems Recent Developments and Future Plans
Figure 28. Cannabis Science Recent Developments and Future Plans
Figure 29. Cellceutix Recent Developments and Future Plans
Figure 30. LEO Pharma Recent Developments and Future Plans
Figure 31. Moberg Pharma Recent Developments and Future Plans
Figure 32. Mylan Recent Developments and Future Plans
Figure 33. Eli Lilly Recent Developments and Future Plans
Figure 34. Bristol Myers Squibb Recent Developments and Future Plans
Figure 35. Boehringer Ingelheim Recent Developments and Future Plans
Figure 36. Aqua Pharmaceuticals Recent Developments and Future Plans
Figure 37. Bausch Health Recent Developments and Future Plans
Figure 38. Merck Recent Developments and Future Plans
Figure 39. Global Skin Cancer Revenue Share by Players in 2020
Figure 40. Skin Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 41. Global Top 3 Players Skin Cancer Revenue Market Share in 2020
Figure 42. Global Top 10 Players Skin Cancer Revenue Market Share in 2020
Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 44. Global Skin Cancer Revenue Share by Type in 2020
Figure 45. Global Skin Cancer Market Share Forecast by Type (2021-2026)
Figure 46. Global Skin Cancer Revenue Share by Application in 2020
Figure 47. Global Skin Cancer Market Share Forecast by Application (2021-2026)
Figure 48. North America Skin Cancer Sales Market Share by Type (2016-2026)
Figure 49. North America Skin Cancer Sales Market Share by Application (2016-2026)
Figure 50. North America Skin Cancer Revenue Market Share by Country (2016-2026)
Figure 51. United States Skin Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Canada Skin Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Mexico Skin Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Europe Skin Cancer Sales Market Share by Type (2016-2026)
Figure 55. Europe Skin Cancer Sales Market Share by Application (2016-2026)
Figure 56. Europe Skin Cancer Revenue Market Share by Country (2016-2026)
Figure 57. Germany Skin Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. France Skin Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. United Kingdom Skin Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Russia Skin Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Italy Skin Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Asia-Pacific Skin Cancer Sales Market Share by Type (2016-2026)
Figure 63. Asia-Pacific Skin Cancer Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Skin Cancer Revenue Market Share by Region (2016-2026)
Figure 65. China Skin Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Japan Skin Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South Korea Skin Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. India Skin Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Southeast Asia Skin Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Australia Skin Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. South America Skin Cancer Sales Market Share by Type (2016-2026)
Figure 72. South America Skin Cancer Sales Market Share by Application (2016-2026)
Figure 73. South America Skin Cancer Revenue Market Share by Country (2016-2026)
Figure 74. Brazil Skin Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Argentina Skin Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Middle East and Africa Skin Cancer Sales Market Share by Type (2016-2026)
Figure 77. Middle East and Africa Skin Cancer Sales Market Share by Application (2016-2026)
Figure 78. Middle East and Africa Skin Cancer Revenue Market Share by Country (2016-2026)
Figure 79. Turkey Skin Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Saudi Arabia Skin Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. UAE Skin Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Methodology
Figure 83. Research Process and Data Source
世界のがん細胞分析市場 2021：企業別、地域別、種類・用途別 The Cancer Cell Analysis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…- 世界の子宮がん治療・診断市場 2021：企業別、地域別、種類・用途別 The Uterine Cancer Therapies and Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 世界の樹状細胞・腫瘍細胞がんワクチン市場 2021：企業別、地域別、種類・用途別 The Dendritic Cell and Tumor Cell Cancer Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 世界の乳がん用CDK4/6阻害薬市場 2021：企業別、地域別、種類・用途別 The CDK4/6 Inhibitors for Breast Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- 世界のALK陽性肺がん治療市場 2021：企業別、地域別、種類・用途別 The ALK Positive Lung Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…